Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
15.90
-0.85 (-5.07%)
Nov 2, 2026, 4:00 PM EST - Market closed
Beta Bionics Revenue
Beta Bionics had revenue of $35.51M in the quarter ending September 30, 2026, with 30.28% growth. This brings the company's total for the last twelve months to $127.27M, up 43.69% year-over-year. In the year 2025, Beta Bionics had annual revenue of $100.25M with 53.94% growth. That makes Beta Bionics the 20,893rd largest company in the world by revenue and 3,148th in the United States.
Revenue (ttm)
$127.27M
Revenue Growth
+43.69%
P/S Ratio
6.79
Revenue / Employee
$300,863
Employees
423
Market Cap
864.44M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.25M | 35.13M | 53.94% |
| Dec 31, 2024 | 65.12M | 53.13M | 442.93% |
| Dec 31, 2023 | 12.00M | 11.82M | 6,601.12% |
| Dec 31, 2022 | 179.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
BBNX News
- 21 hours ago - Kaplan Fox Reminds Investors of Beta Bionics, Inc. (BBNX) of the Deadline to Seek Lead Plaintiff Status on November 3, 2026 - Newsfile Corp
- 3 days ago - Kaplan Fox Encourages Beta Bionics, Inc. (BBNX) Investors With Significant Losses to Take Action Before the November 3, 2026 Lead Plaintiff Deadline - Newsfile Corp
- 5 days ago - DEADLINE NEXT WEEK: Berger Montague Advises Beta Bionics, Inc. (BBNX) Investors to Contact the Firm Before November 3, 2026 - Newsfile Corp
- 5 days ago - Beta Bionics price target raised to $21 from $18 at TD Cowen - TheFly
- 5 days ago - Beta Bionics price target raised to $24 from $20 at Piper Sandler - TheFly
- 5 days ago - Beta Bionics price target raised to $22 from $20 at BofA - TheFly
- 6 days ago - Beta Bionics Earnings Call Transcript: Q3 2026 - Transcripts
- 6 days ago - Beta Bionics Earnings release: Q3 2026 - Filings